T1	Temporal 22 36	within 28 days
T2	Context_Error 0 63	Recent participation (within 28 days) in other research studies
T3	Post-eligibility 0 63	Recent participation (within 28 days) in other research studies
T4	Procedure 84 98	blood donation
T5	Procedure 102 117	plasma donation
*	OR T5 T4
T6	Qualifier 72 83	significant
T8	Temporal 65 71	Recent
T9	Scope 84 117	blood donation or plasma donation
R1	Has_qualifier Arg1:T9 Arg2:T6	
R2	Has_temporal Arg1:T9 Arg2:T8	
T10	Undefined_semantics 72 83	significant
T7	Condition 119 127	Pregnant
T11	Condition 131 140	lactating
*	OR T11 T7
T13	Value 147 155	positive
T14	Temporal 156 168	at screening
T15	Measurement 173 207	human immunodeficiency virus (HIV)
T16	Measurement 249 272	hepatitis C virus (HCV)
T17	Measurement 209 244	hepatitis B surface antigen (HbsAg)
*	OR T15 T17 T16
T12	Scope 173 272	human immunodeficiency virus (HIV), hepatitis B surface antigen (HbsAg), or hepatitis C virus (HCV)
R3	Has_value Arg1:T12 Arg2:T13	
R4	Has_temporal Arg1:T12 Arg2:T14	
T18	Condition 313 323	alcoholism
T19	Condition 327 337	drug abuse
T20	Observation 290 297	history
T21	Mood 301 309	evidence
*	OR T21 T20
T22	Temporal 274 280	Recent
T23	Temporal 282 288	2-year
R5	Subsumes Arg1:T22 Arg2:T23	
*	OR T18 T19
T24	Scope 313 337	alcoholism or drug abuse
T25	Scope 290 309	history or evidence
R6	Has_scope Arg1:T24 Arg2:T25	
R7	Has_temporal Arg1:T24 Arg2:T22	
T26	Post-eligibility 339 550	History or presence of significant cardiovascular, pulmonary, hepatic, gallbladder or biliary tract, renal, hematologic, gastrointestinal, endocrine, immunologic, dermatologic, neurologic, or psychiatric disease
T27	Drug 579 584;599 615;626 655	drugs known to inhibit cytochrome (CYP) P450 enzymes
T28	Drug 579 584;599 607;619 655	drugs known to induce cytochrome (CYP) P450 enzymes
*	OR T28 T27
T29	Drug 579 584;599 615;663 684	drugs known to inhibit P-glycoprotein (P-gp)
T30	Drug 579 584;599 607;619 625;663 684	drugs known to induce P-glycoprotein (P-gp)
T31	Temporal 685 723	within 28 days prior to the first dose
T32	Temporal 728 748	throughout the study
T33	Scope 579 684	drugs or substances known to inhibit or induce cytochrome (CYP) P450 enzymes and/or P-glycoprotein (P-gp)
R8	Has_temporal Arg1:T33 Arg2:T31	
R9	Has_temporal Arg1:T33 Arg2:T32	
T34	Condition 755 764	allergies
T36	Drug 768 783	quinine sulfate
T37	Drug 787 800	rosiglitazone
T35	Scope 768 800	quinine sulfate or rosiglitazone
*	OR T37 T36
R10	Has_scope Arg1:T34 Arg2:T35	
